loading...| Preferred Name |
azilsartan medoxomil |
|
| Synonyms |
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1-benzimidazole-7-carboxylate azilsartanum medoxomilum Edarbi (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate C30H24N4O8 azilsartan medoxomil azilsartan medoxomilo |
|
| ID |
http://purl.obolibrary.org/obo/CHEBI_68845 |
|
| AHFScode |
24:32.08 |
|
| ATCCode |
C09CA09 |
|
| blocks | ||
| DBBrand |
edarbi |
|
| DBSalt |
azilsartan kamedoxomil azilsartan medoxomil potassium |
|
| DBSynonym |
azilsartan tak-536 azilsartanum medoxomilum edarbi azilsartan tak-491 azilsartan medoxomilo |
|
| Definition |
A carboxylic ester obtained by formal condensation of the carboxy group of azilsartan with the hydroxy group of 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one. A prodrug for azilsartan, it is used for treatment of hypertension. Azilsartan medoxomil is an angiotensin II receptor antagonist indicated for the treatment of mild to moderate essential hypertension. Azilsartan medoxomil is a prodrug of Azilsartan marketed as "Edarbi" by Takeda. Azilsartan medoxomil has so far been shown to be superior to olmesartan and valsartan in lowering blood pressure. |
|
| has pharmacological target | ||
| has role |
http://purl.obolibrary.org/obo/CHEBI_61016 |
|
| InChI |
InChI=1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36) InChI=1/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36) |
|
| InChIKey |
InChIKey=QJFSABGVXDWMIW-UHFFFAOYNA-N InChIKey=QJFSABGVXDWMIW-UHFFFAOYSA-N |
|
| label |
azilsartan medoxomil |
|
| may interact with |
http://purl.obolibrary.org/obo/CHEBI_5004 http://purl.obolibrary.org/obo/CHEBI_63608 http://purl.obolibrary.org/obo/dinto_DB00519 http://purl.obolibrary.org/obo/CHEBI_9352 http://purl.obolibrary.org/obo/CHEBI_71940 http://purl.obolibrary.org/obo/CHEBI_66876 http://purl.obolibrary.org/obo/CHEBI_8024 http://purl.obolibrary.org/obo/CHEBI_71193 http://purl.obolibrary.org/obo/CHEBI_49662 http://purl.obolibrary.org/obo/CHEBI_601027 http://purl.obolibrary.org/obo/CHEBI_8249 http://purl.obolibrary.org/obo/CHEBI_8713 http://purl.obolibrary.org/obo/CHEBI_15365 http://purl.obolibrary.org/obo/CHEBI_41423 http://purl.obolibrary.org/obo/CHEBI_8774 http://purl.obolibrary.org/obo/CHEBI_9334 http://purl.obolibrary.org/obo/CHEBI_7476 http://purl.obolibrary.org/obo/CHEBI_7822 http://purl.obolibrary.org/obo/CHEBI_39669 http://purl.obolibrary.org/obo/CHEBI_5855 http://purl.obolibrary.org/obo/dinto_DB00461 http://purl.obolibrary.org/obo/CHEBI_72014 http://purl.obolibrary.org/obo/dinto_DB00691 http://purl.obolibrary.org/obo/dinto_DB01356 http://purl.obolibrary.org/obo/CHEBI_5130 http://purl.obolibrary.org/obo/CHEBI_3380 http://purl.obolibrary.org/obo/dinto_DB00939 http://purl.obolibrary.org/obo/dinto_DB04272 http://purl.obolibrary.org/obo/CHEBI_28787 http://purl.obolibrary.org/obo/CHEBI_5163 http://purl.obolibrary.org/obo/CHEBI_3011 http://purl.obolibrary.org/obo/dinto_DB00784 http://purl.obolibrary.org/obo/CHEBI_43755 http://purl.obolibrary.org/obo/CHEBI_4909 http://purl.obolibrary.org/obo/dinto_DB00073 http://purl.obolibrary.org/obo/dinto_DB00814 http://purl.obolibrary.org/obo/dinto_DB00465 http://purl.obolibrary.org/obo/CHEBI_6128 http://purl.obolibrary.org/obo/CHEBI_2636 http://purl.obolibrary.org/obo/CHEBI_4784 |
|
| prefixIRI |
obo2:CHEBI_68845 |
|
| prefLabel |
azilsartan medoxomil |
|
| SMILES |
CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1 CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(cc1)-c1ccccc1-c1noc(=O)[nH]1 |
|
| Synonym |
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1-benzimidazole-7-carboxylate azilsartanum medoxomilum Edarbi (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate C30H24N4O8 azilsartan medoxomil azilsartan medoxomilo |
|
| xref |
CiteXplore:21558880 CiteXplore:21971539 CiteXplore:21566544 Wikipedia:Azilsartan CiteXplore:22346296 Drugs.com:http://www.drugs.com/ingredient/azilsartan-medoxomil.html KEGG DRUG:D08067 CiteXplore:21069103 CiteXplore:22661897 Patent:US2005187269 CiteXplore:21986624 CiteXplore:21816148 CiteXplore:22365278 Reaxys:12326818 CiteXplore:22710649 CASRN:863031-21-4 CiteXplore:22116996 CiteXplore:22533654 CiteXplore:22939358 CiteXplore:22877322 National Drug Code Directory:64764-844-30 RxList:http://www.rxlist.com/edarbi-drug.htm CiteXplore:21272195 CiteXplore:21282560 CiteXplore:21762358 CiteXplore:21555300 ChEBI:68845 CiteXplore:22457601 CiteXplore:22071238 Wikipedia:http://en.wikipedia.org/wiki/Azilsartan ChEMBL:1440892 |
|
| subClassOf |